Lanoxin and Colcrys drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Lanoxin (digoxin) and Colcrys (colchicine). Common drug interactions include pulmonary hypertension among females and haematuria among males.
The phase IV clinical study analyzes what interactions people have when they take Lanoxin and Colcrys. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.
What is Lanoxin?
Lanoxin has active ingredients of digoxin. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 21,852 Lanoxin users. Check the latest studies of Lanoxin.
What is Colcrys?
Colcrys has active ingredients of colchicine. It is often used in gout. eHealthMe is studying from 4,546 Colcrys users. Check the latest studies of Colcrys.
18 people who take Lanoxin and Colcrys together, and have interactions are studied.

What are the common drug interactions of Lanoxin and Colcrys, by gender? *:
female:
- Pulmonary hypertension (increase in blood pressure in the lung artery)
- Vomiting
- Arthralgia (joint pain)
- Constipation
- Nausea (feeling of having an urge to vomit)
- Blood glucose increased
- Bone atrophy (decrease in bone mass)
- Bone pain
- Cardiac failure
- Death
male:
- Haematuria (presence of blood in urine)
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
- Hernia (hernia happens when part of an internal organ or tissue bulges through a weak area of muscle)
- Peripheral ischaemia (impaired circulation to an extremity)
- Death
- Drug ineffective
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
What are the common drug interactions of Lanoxin and Colcrys, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Acute respiratory failure
- Dehydration (dryness resulting from the removal of water)
- Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
- Pulmonary hypertension (increase in blood pressure in the lung artery)
- Vomiting
- Nausea (feeling of having an urge to vomit)
- Death
- Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
30-39:
n/a
40-49:
n/a
50-59:
- Haematuria (presence of blood in urine)
60+:
- Constipation
- Arthralgia (joint pain)
- Glycosylated haemoglobin increased
- Haematuria (presence of blood in urine)
- Lower limb fracture
- Pain in extremity
- Procedural pain
- Rotator cuff syndrome (a spectrum of conditions affecting the rotator cuff tendons of the shoulder)
- Speech disorder
- Viral upper respiratory tract infection
What are the existing conditions these people have? *
- Hyperkalemia (damage to or disease of the kidney): 3 people, 16.67%
- Pulmonary Hypertension (increase in blood pressure in the lung artery): 3 people, 16.67%
- Pain: 2 people, 11.11%
- High Blood Cholesterol: 2 people, 11.11%
- Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 11.11%
- Parkinson's Disease: 2 people, 11.11%
- Chronic Kidney Disease: 2 people, 11.11%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 11.11%
- Cough: 1 person, 5.56%
- Cardiac Failure Congestive: 1 person, 5.56%
* Approximation only. Some reports may have incomplete information.
Do you take Lanoxin and Colcrys?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Lanoxin and Colcrys:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Lanoxin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Colcrys:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Lanoxin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Colcrys and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Guru SR, Suresh A, Padmanabhan S, Reddy A, "A Rare Case of Digoxin Associated Gingival Overgrowth", Journal of clinical and diagnostic research: JCDR, 2017 Jan .
- Lai SW, Lin CL, Liao KF, "Digoxin use may increase the relative risk of acute pancreatitis: a population-based case–control study in Taiwan", International journal of cardiology, 2015 Feb .
- Guru SR, Suresh A, Padmanabhan S, Reddy A, "A Rare Case of Digoxin Associated Gingival Overgrowth", Journal of clinical and diagnostic research: JCDR, 2017 Jan .
- Lai SW, Lin CL, Liao KF, "Digoxin use may increase the relative risk of acute pancreatitis: a population-based case–control study in Taiwan", International journal of cardiology, 2015 Feb .
How the study uses the data?
The study uses data from the FDA. It is based on digoxin and colchicine (the active ingredients of Lanoxin and Colcrys, respectively), and Lanoxin and Colcrys (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Rituxan and Shock - Anaphylactic for Women aged 50-59 - a second ago
- Rituxan and Anaphylactic Shock for Women aged 50-59 - a second ago
- Rituxan and Anaphylactic Reaction for Women aged 50-59 - a second ago
- Rituxan and Anaphylaxis for Women aged 50-59 - 2 seconds ago
- Could Mycophenolate Mofetil cause Stent? - 3 seconds ago
- Pepcid and Ldl/Hdl Ratio Increased for Women aged 30-39 - 15 seconds ago
- Drug interactions of Xopenex and Prednisone - 16 seconds ago
- Pepcid and Lipid Disorders for Women aged 30-39 - 16 seconds ago
- Pepcid and Hyperlipoproteinemia for Women aged 30-39 - 16 seconds ago
- Pepcid and Hyperlipidemia for Women aged 30-39 - 17 seconds ago